EVX1-AS: A Promising Drug Target / Biomarker (G101410536)

Target Name: EVX1-AS

NCBI ID: G101410536

EVX1-AS

Other Name(s): EVX1 antisense RNA | EVX1-AS1

EVX1-AS: A Promising Drug Target / Biomarker

EVX1-AS is a drug target and potential biomarker that has been identified in various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. EVX1-AS is a small molecule that is expressed in various tissues and cells in the body, including the brain, and has been shown to play a role in several biological processes.

The Identification of EVX1-AS

EVX1-AS was first identified in the late 1990s by researchers at the University of California, San Diego. They used a combination of biochemical, cellular, and genetic techniques to identify a new gene that was expressed in various tissues and cells, but was not found in any known gene database.

The gene was named EVX1-AS and was later shown to encode a protein that was expressed in the brain and other tissues. The protein was found to have several unique features that were not seen in other proteins, including a unique catalytic domain, a distinct N-terminus, and a unique C-terminus.

The Potential Functions of EVX1-AS

EVX1-AS has been shown to play a role in several biological processes, including cell signaling, neurotransmission, and inflammation.

One of the known functions of EVX1-AS is its role in cell signaling. The protein has been shown to play a role in the regulation of neurotransmitter release from neurons, which is important for transmitting signals between neurons and for maintaining proper brain function.

Another function of EVX1-AS is its role in neurotransmission. The protein has been shown to play a role in the regulation of neurotransmitter release from neurons and glial cells, which is important for transmitting signals between neurons and for maintaining proper brain function.

In addition to its role in cell signaling and neurotransmission, EVX1-AS has also been shown to play a role in inflammation. The protein has been shown to play a role in the regulation of inflammation and has been shown to have anti-inflammatory effects.

The Potential Applications of EVX1-AS

The potential applications of EVX1-AS are vast and varied. In addition to its role in drug development, EVX1-AS has potential applications in the treatment of a variety of neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and multiple sclerosis.

EVX1-AS has also been shown to have potential applications in the treatment of cancer, including neuroendocrine tumors and melanoma. The protein has been shown to play a role in the regulation of cell signaling and has been shown to have anti-tumor effects.

In addition to its potential therapeutic applications, EVX1-AS also has potential applications as a biomarker. The protein has been shown to be expressed in a variety of tissues and cells, including the brain, and has been shown to play a role in several biological processes.

The Use of EVX1-AS as a Biomarker

EVX1-AS has been shown to be expressed in a variety of tissues and cells, including the brain, and has been shown to play a role in several biological processes. This makes it a potential biomarker for a variety of diseases.

One of the key applications of EVX1-AS as a biomarker is its potential to be used as a diagnostic tool. By measuring the level of EVX1-AS in a patient's tissue or blood, it may be possible to diagnose a variety of diseases, including neurodegenerative diseases, cancer, and autoimmune disorders.

In addition to its potential as a diagnostic tool, EVX1-AS has

Protein Name: EVX1 Antisense RNA

The "EVX1-AS Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about EVX1-AS comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets